Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Menu

Immatics NV (IMTX)

Immatics NV (IMTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Immatics N.V. Reports Promising Clinical Data for TCR Bispecific Molecules and Advances Four Cancer Therapy Candidates Quiver Quantitative, Inc. - Mon Nov 18, 4:16PM CST

Immatics targets five cancer types with TCR-T therapies; recent data shows promising results for TCER® IMA402 and ACTengine® IMA203.Quiver AI SummaryImmatics N.V. announced a strategic expansion of its...

IMTX : 6.85 (-0.44%)
Immatics: Q3 Earnings Snapshot AP - Mon Nov 18, 6:07AM CST

Immatics: Q3 Earnings Snapshot

IMTX : 6.85 (-0.44%)
Immatics: Q2 Earnings Snapshot AP - Tue Aug 13, 6:09AM CDT

Immatics: Q2 Earnings Snapshot

IMTX : 6.85 (-0.44%)
Immatics: Q1 Earnings Snapshot AP - Tue May 14, 6:13AM CDT

Immatics: Q1 Earnings Snapshot

IMTX : 6.85 (-0.44%)
Immatics: Q3 Earnings Snapshot AP - Tue Nov 14, 2023

Immatics: Q3 Earnings Snapshot

IMTX : 6.85 (-0.44%)
Protalix BioTherapeutics Appoints Eliot Richard Forster, Ph.D. as Chairman of its Board of Directors PR Newswire - Tue Sep 12, 2023

/PRNewswire / Protalix BioTherapeutics, Inc. (NYSE American: PLX), a biopharmaceutical company focused on the development, production and commercialization of...

IMTX : 6.85 (-0.44%)
PLX : 1.7600 (+1.15%)
Moderna and Immatics Announce Strategic Multi-Platform Collaboration to Develop Innovative Oncology Therapeutics ACCESSWIRE - Mon Sep 11, 2023

Collaboration combines leading technologies to develop breakthrough, mRNA-enabled in vivo expressed TCER® molecules

MRNA : 39.39 (-0.43%)
IMTX : 6.85 (-0.44%)
Immatics: Q2 Earnings Snapshot AP - Thu Aug 17, 2023

Immatics: Q2 Earnings Snapshot

IMTX : 6.85 (-0.44%)
Immatics: Q1 Earnings Snapshot AP - Tue May 16, 2023

Immatics: Q1 Earnings Snapshot

IMTX : 6.85 (-0.44%)
Why Immatics Stock Is Soaring Today Motley Fool - Tue May 2, 2023

Investors liked what they heard in Immatics' interim results for experimental immunotherapy IMA203.

IMTX : 6.85 (-0.44%)

Barchart Exclusives

How To Profit From The Latest Corporate Spinoffs: A Guide For Investors In 2025 Barchart - 27 minutes ago
How to navigate corporate spinoffs. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot